Chronically decreased PC expression in liver and adipose tissue was demonstrated to reduce plasma glucose concentrations, the rate of endogenous glucose production, adiposity, plasma lipid concentrations, hepatic steatosis and improved hepatic insulin sensitivity [55]. This evidence concerns the gene INS and fatty liver disease.